FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in …
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most …
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
2023年11月8日 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster …
F.D.A. Approves New Obesity Drug That Will Compete With …
2023年11月8日 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy. The …
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight ...
INDIANAPOLIS, Nov. 8, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and …
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
2023年11月8日 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity …
What is the pipeline for future medications for obesity?
2024年2月1日 · In this review, we present the efficacy and safety data for the pipeline of obesity pharmacotherapies with a focus on entero-pancreatic hormone-based treatments and we …
FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new …
2023年11月8日 · The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a …
Powerful new obesity drug poised to upend weight loss care
2023年4月27日 · Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity …
Questions and answers about the new anti-obesity medications
2024年1月1日 · A blockbuster batch of anti-obesity drugs continues to grab headlines and dominate social media posts, and not just because the new year revs up our resolve to shed …